Kantor and colleagues from the Hospital for Sick Children in Toronto, Canada have reported that outcomes for medically treated pediatric patients with dilated cardiomyopathy (DCM) have not changed over a 30-year period, despite institution of neurohormonal inhibition therapy. These findings are placed in the context of the worldwide experience of pediatric DCM and the limited number of studies of neurohormonal inhibition therapy in children with heart failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Daubeney, P. E. et al. for the National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114, 2671–2678 (2006).
Towbin, J. A. et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296, 1867–1876 (2006).
Kantor, P. F., Abraham, J. R., Dipchand, A. I., Benson, L. N. & Redington, A. N. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J. Am. Coll. Cardiol. 55, 1377–1384 (2010).
Krum, H. & Abraham, W. T. Heart failure. Lancet 373, 941–955 (2009).
Dipchand, A. I. et al. for the Pediatric Heart Transplant Study Investigators. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study. J. Heart Lung Transplant. 28, 1312–1321 (2009).
Tsirka, A. E. et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J. Am. Coll. Cardiol. 44, 391–397 (2004).
Duboc, D. et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J. Am. Coll. Cardiol. 45, 855–857 (2005).
Shaddy, R. E. et al. for the Pediatric Carvedilol Study Group. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298, 1171–1179 (2007).
Moon, J. et al. Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy. Can. J. Cardiol. 25, e147–e150 (2009).
Harmon, W. G. et al. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am. J. Cardiol. 10 4, 281–286 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Canter, C. Treating pediatric DCM—great expectations unfulfilled. Nat Rev Cardiol 7, 420–422 (2010). https://doi.org/10.1038/nrcardio.2010.87
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.87
